Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
EditorialEditorial

Cannabis in the Treatment of Rheumatic Diseases: Suggestions for a Reasoned Approach

HAROLD KALANT
The Journal of Rheumatology February 2015, 42 (2) 146-148; DOI: https://doi.org/10.3899/jrheum.140683
HAROLD KALANT
Department of Pharmacology & Toxicology, University of Toronto and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: harold.kalant@utoronto.ca
  • Article
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

REFERENCES

  1. 1.↵
    1. Kalant H
    . Marihuana: Medicine, addictive substance, or both? A common-sense approach to the place of cannabis in medicine. Can J Addict 2013;4(3):4–8.
    OpenUrl
  2. 2.↵
    1. Fitzcharles M,
    2. Jamal S
    . Expanding medical marijuana access in Canada: considerations for the rheumatologist. J Rheumatol 2015;42:143–5.
    OpenUrlFREE Full Text
  3. 3.↵
    Canadian Charter of Rights and Freedoms. Catalogue No. S2-215/2003. Ottawa: Minister of Public Works and Government Services Canada; 2003.
  4. 4.↵
    Canada: Pot; A Case For Fair Play. Source: Toronto Star. Publication date: December 12, 1997. [Internet. Accessed June 12, 2014.] Available from: www.cfdp.ca/dec1097.htm
  5. 5.↵
    Health Canada. Cannabis (marihuana, marijuana) and the cannabinoids. February 2013. [Internet. Accessed June 6, 2014.] Available from: www.hc-sc.gc.ca/dhp-mps/alt_formats/pdf/marihuana/med/infoprof-eng.pdf
  6. 6.↵
    1. Rahn EJ,
    2. Hohmann AG
    . Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside. Neurotherapeutics 2009;6:713–37.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Anand P,
    2. Whiteside G,
    3. Fowler CJ,
    4. Hohmann AG
    . Targeting CB2 receptors and the endocannabinoid system for the treatment of pain. Brain Res Rev 2009 Apr;60:255–66.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Kress M,
    2. Kuner R
    . Mode of action of cannabinoids on nociceptive nerve endings. Exp Brain Res 2009;196:79–88.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. McDougall JJ
    . Peripheral analgesia: hitting pain where it hurts. Biochimica et Biophysica Acta 2011;1812:459–67.
    OpenUrlPubMed
  10. 10.↵
    1. Zhang RX,
    2. Ren K,
    3. Dubner R
    . Osteoarthritis pain mechanisms: basic studies in animal models. Osteoarthritis Cartilage 2013;21:1308–15.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Stein C,
    2. Machelska H
    . Modulation of peripheral sensory neurons by the immune system: implications for pain therapy. Pharmacol Rev 2011;63:860–81.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Namazi MR
    . Cannabinoids, loratidine and allopurinol as novel additions to the antipsoriatic ammunition. J Eur Acad Dermatol Venereol 2005;19:319–22.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Pacher P,
    2. Kunos G
    . Modulating the endocannabinoid system in human health and disease – successes and failures. FEBS J 2013;280:1918–43.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Elikkottil J,
    2. Gupta P,
    3. Gupta K
    . The analgesic potential of cannabinoids. J Opioid Manag 2009;5:341–57.
    OpenUrlPubMed
  15. 15.↵
    1. Kalant H
    . Adverse effects of cannabis on health: an update on the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:849–63.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Hall W,
    2. Degenhardt L
    . Adverse health effects of non-medical cannabis use. Lancet 2009;374:1383–91.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Ware MA,
    2. Wang T,
    3. Shapiro S,
    4. Robinson A,
    5. Ducruet T,
    6. Huynh T,
    7. et al.
    Smoked cannabis for chronic neuropathic pain: a randomized clinical trial. CMAJ 2010;182:E694–701.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Wang T,
    2. Collet JP,
    3. Shapiro S,
    4. Ware MA
    . Adverse effects of medical cannabinoids: a systematic review. CMAJ 2008;178:1669–78.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Ben Amar M
    . Cannabinoids in medicine: a review of their therapeutic potential. J Ethnopharmacol 2006;105:1–25.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Meier MH,
    2. Caspi A,
    3. Ambler A,
    4. Harrington H,
    5. Houts R,
    6. Keefe RS,
    7. et al.
    Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A 2012;109:E2657–64.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Preece PM,
    2. Riley E
    1. Fried PA
    . Cannabis use during pregnancy: its effects on offspring from birth to young adulthood. In: Preece PM, Riley E, editors. Alcohol, drugs and medication in pregnancy: the long-term outcome for the child. London, UK: Mac Keith Press, Blackwell Publishing; 2011:153–68.
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 42, Issue 2
1 Feb 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cannabis in the Treatment of Rheumatic Diseases: Suggestions for a Reasoned Approach
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cannabis in the Treatment of Rheumatic Diseases: Suggestions for a Reasoned Approach
HAROLD KALANT
The Journal of Rheumatology Feb 2015, 42 (2) 146-148; DOI: 10.3899/jrheum.140683

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Cannabis in the Treatment of Rheumatic Diseases: Suggestions for a Reasoned Approach
HAROLD KALANT
The Journal of Rheumatology Feb 2015, 42 (2) 146-148; DOI: 10.3899/jrheum.140683
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • REFERENCES
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • The Patient Experience of Drug Side Effects in Rheumatoid Arthritis: Intriguing Data From an Exploratory Online Survey
  • The Challenge of Addressing the Rheumatology Workforce Shortage
  • Alterations of Plasma Microbiome: A Potentially New Perspective to the Dysbiosis in Systemic Lupus Erythematosus?
Show more Editorial

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire